Whole‐exome sequencing of non‐BRCA1/BRCA2 mutation carrier cases at high‐risk for hereditary breast/ovarian cancer

The current study aimed to identify new breast and/or ovarian cancer predisposition genes. For that, whole‐exome sequencing (WES) was performed in the germline DNA of 52 non‐BRCA1/BRCA2/TP53 mutation carrier women at high‐risk for hereditary breast and ovarian cancer (HBOC). All variants were classi...

Descripción completa

Detalles Bibliográficos
Autores principales: Felicio, Paula S., Grasel, Rebeca S., Campacci, Natalia, de Paula, Andre E., Galvão, Henrique C. R., Torrezan, Giovana T., Sabato, Cristina S., Fernandes, Gabriela C., Souza, Cristiano P., Michelli, Rodrigo D., Andrade, Carlos E., Barros, Bruna Durães De Figueiredo, Matsushita, Marcus M., Revil, Timothée, Ragoussis, Jiannis, Couch, Fergus J., Hart, Steven N., Reis, Rui M., Melendez, Matias E., Tonin, Patricia N., Carraro, Dirce M., Palmero, Edenir I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898723/
https://www.ncbi.nlm.nih.gov/pubmed/33326660
http://dx.doi.org/10.1002/humu.24158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898723/
https://www.ncbi.nlm.nih.gov/pubmed/33326660
http://dx.doi.org/10.1002/humu.24158

Ejemplares similares